BIOMEBANK
BiomeBank is a clinical stage biotechnology company developing microbial therapies to treat unmet medical need globally, with an immediate focus on the APAC region. We currently manufacture a microbial therapy to treat Clostridoides difficile, a potentially life threatening infection, and are positioning the drug product for multiple indications. Furthermore, we are actively developing second generation therapies in multiple diseases, including Ulcerative Colitis and Crohn's Disease.
BIOMEBANK
Industry:
Biopharma Biotechnology Manufacturing
Founded:
2018-01-01
Address:
Adelaide, South Australia, Australia
Country:
Australia
Total Employee:
11+
Status:
Active
Contact:
08 8152 9370
Email Addresses:
[email protected]
Similar Organizations
Amino Medical Science
Amino Medical Science is a clinical stage biotechnology company that pioneers first-in-class therapeutic treatments
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
miRecule
MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics.
Founder
More informations about "BiomeBank"
BiomeBank - Restoring gut microbial ecology
BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.See details»
The Team - Biome Bank
BiomeBank is made up of a team of drug development experts based in a new world-class cGMP manufacturing facility in the heart of Adelaide’s medical precinct.See details»
Investing in BiomeBank - a leading biotechnology company
BiomeBank is well-positioned to become a global leader in the discovery and commercialisation of microbial therapies. Our current donor-derived therapy is the world’s first approved …See details»
Technology | BiomeBank - a leading biotechnology …
BiomeBank has developed a breakthrough platform that has enabled us to generate an artificial human gut microbial community in a bioreactor – the …See details»
BiomeBank - Crunchbase Company Profile & Funding
BiomeBank is a clinical stage biotechnology company developing microbial …See details»
BiomeBank 2025 Company Profile: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for BiomeBank. Use the PitchBook Platform to explore the full profile.See details»
Patient - Biome Bank
BiomeBank microbiome-based therapies harness the gut microbiota to treat chronic and infectious disease. Our product is the first microbiome-based …See details»
News - Biome Bank
Apr 15, 2024 The translation of research into the development of innovative and life-saving microbial therapies is set to transform in Australia through a partnership between Hudson …See details»
BiomeBank - SAVCFund
BiomeBank is a clinical stage biotechnology company with a mission to treat and prevent disease by restoring gut microbial ecology. BiomeBank is on a mission to discover and develop new …See details»
BiomeBank - Latest News
Apr 15, 2024 Get the latest information on BiomeBank, our products, and other important topics in microbiome science.See details»
BiomeBank - YouTube
Harnessing ecology to deliver novel, cultured microbial therapies . BiomeBank is an Australian clinical stage biotechnology company with a mission to treat and prevent disease by restoring …See details»
BiomeBank - The Org
BiomeBank is a clinical stage biotechnology company developing microbial therapies to treat unmet medical need globally, with an immediate focus on the APAC region. We currently …See details»
BiomeBank - 2025 Company Profile & Team - Tracxn
Jun 23, 2025 BiomeBank is a series B company based in Thebarton (Australia), founded in 2018 by Sam Costello. It operates as a Developer of microbial therapies to treat diseases. …See details»
BiomeBank - IMCRC
Clinical stage biotechnology company BiomeBank specialises in Faecal Microbiota Transplantation (FMT) therapy, which involves transplanting the microbial community from a …See details»
BiomeBank Secures $4M to Revolutionize Gut Health and …
Mar 10, 2025 BiomeBank is excited to announce that it has successfully raised $4,000,000 in its latest funding round—a significant milestone that will accelerate its pioneering work in …See details»
Inside BiomeBank How Engineered Microbial Consortia Are …
Jul 8, 2025 BiomeBank’s Consortiomeâ„¢ platform marks a basic alteration in treating chronic disease—equalizing the gut microbiome with customized, lab-grown microbial communities. …See details»
BiomeBank - Products, Competitors, Financials, Employees, …
BiomeBank is a clinical stage biotechnology company focused on restoring gut microbial ecology within the healthcare sector. The company develops microbiome-based therapies, including a …See details»
BiomeBank - VentureRadar
BiomeBank is a clinical stage biotechnology company developing a pipeline of microbiome-based therapies to treat unmet medical need. BiomeBank’s mission is to treat and prevent disease by …See details»
Newsroom - AusBiotech Ltd
Jul 23, 2025 By profiling members like BiomeBank, we help connect Australia’s life sciences ecosystem — including innovators, investors, policymakers, and partners — and elevate out …See details»
BiomeBank | LinkedIn
BiomeBank is proud to be part of a growing biotech sector in Australia—one that’s harnessing cutting-edge science and creating global impact. As the world’s only company with patented …See details»